언어선택 ENG
KOR ENG
전체메뉴
전체메뉴 닫기

News

Innovative Medicines based on
ImmunoModulatory Biologics

Patent registration of ePENDY platform technology in Korea

  • Date
    2024-02-19 17:57:47
  • View
    565
For more information, please visit : IMBiologics  News (full article available in Korean)
Prev
IMB-101, Selection of the top 10 excellent projects for KDDF 2023
Next
Signing a joint research agreement with Dong-A ST using ePENDY platform technolo...
목록
  • President(CEO) : Gyongsik Ha
  • 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea